Target intelligence / Profile preview

Human Rhinovirus 16 capsid protein VP1 hydrophobic pocket (HRV16 VP1 pocket)

Target
HRV16 VP1 pocket
Molecular classification
Viral capsid protein, Structural protein
01

Overview

The VP1 hydrophobic pocket of Human Rhinovirus 16 (HRV16) is a specialized cavity located within the VP1 protein of the viral capsid, situated beneath the floor of the “canyon” which serves as the binding site for the host cell receptor ICAM-1 [1][2]. In its native state, this pocket is often occupied by a host-derived “pocket factor,” typically a fatty acid-like molecule, which maintains the structural stability of the virion [2]. During the infection process, the displacement of this pocket factor is a prerequisite for the conformational changes required for viral uncoating and the subsequent release of the viral RNA into the host cytoplasm [1][4]. Therapeutic agents known as capsid binders, such as Pleconaril, target this pocket by binding with higher affinity than the natural pocket factor, thereby over-stabilizing the capsid and preventing the uncoating process [3][5]. This mechanism effectively halts viral replication at the early entry stage, making the VP1 pocket a focal point for antiviral strategies against HRV-mediated respiratory illnesses, including the common cold and exacerbations of asthma or COPD [3][5]. Citations: [1] Rossmann MG, et al. Nature. 1985;317(6033):145-153. [2] Oliveira MA, et al. Structure. 1993;1(1):51-68. [3] Pevear DC, et al. Antimicrob Agents Chemother. 1999;43(9):2109-2115. [4] Ledford RM, et al. J Virol. 2004;78(7):3663-3674. [5] Rotbart HA. Antiviral Res. 2002;53(2):83-98.

Other names
HRV16 VP1 canyonVP1 hydrophobic cavityCapsid binding pocketWIN-binding pocket
02

Mechanism of action

Capsid stabilization and inhibition of viral uncoating

03

Biological functions

Viral entryViral uncoatingViral attachmentCapsid assembly
04

Disease associations

InfectionCommon coldAsthma exacerbationChronic obstructive pulmonary disease exacerbation
05

Safety considerations

Drug resistanceCYP3A4 inductionLimited clinical efficacy
06

Interacting drugs

Pleconaril

4 more in the full profile.

07

Biomarkers

Viral loadViral RNA detection

Beyond the preview

Go deeper on Human Rhinovirus 16 capsid protein VP1 hydrophobic pocket (HRV16 VP1 pocket).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Human Rhinovirus 16 capsid protein VP1 hydrophobic pocket (HRV16 VP1 pocket).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call